touchONCOLOGY spoke to Professor Pamela Kearns (University of Birmingham, UK) to discuss the importance of SIOP Europe, and the power of bringing together experts, patients and parents from the continent as one voice with one objective.
- Why is it important to have organizations like SIOP Europe? (00:21-02:09)
- Is there any message you would like to share with the community as the Past President of SIOP Europe? (02:09-06:50)
Disclosure: Pamela Kearns has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Share this Video
Related Videos In Paediatric Oncology
Pamela Kearns: Exciting steps forward through collaborative clinical trials in paediatric oncology
Professor Pamela Kearns (Director, Cancer Research UK Clinical Trials Unit, UK) discusses some of the most important clinical trials she is currently involved with in the field of paediatric oncology. She includes: The Glo-BNHL trial, which is the largest platform trial in paediatric and adolescent relapsed and refractory B-cell malignancies globally (0:32) INTER-EWING, a clinical […]
Pamela Kearns: Highlights from SIOP Europe 2023
Professor Pamela Kearns (University of Birmingham, UK) joins touchONCOLOGY to discuss her highlights from the first face-to-face annual meeting of the European Society of Paediatric Oncology (SIOPE Europe) since the COVID-19 pandemic (Valencia, 8-12 May 2023). She celebrates joint sessions with patient advocacy groups, and the importance of patient and parent experience in the debate […]
Carmelo Rizzari: Highlights from the SIOPE Europe 2023 Annual Meeting!
President of the European Society for Paediatric Oncology (SIOPE Europe), Prof Carmelo Rizzari, discusses his highlights from the SIOPE Europe 2023 annual meeting. This year it was attended by 1200 individuals, bringing together healthcare professionals, parents, patients, caregivers, young oncologists, nurses and many other groups involved in the paediatric oncology. There were 150 sessions and […]
Journal articles and more to your inbox
Get the latest clinical insights from touchONCOLOGYSign me up!